RABIOPRED - a Validation Study of Theranostic Test to PREDict Treatment Response of Anti-TNFα BIologicals in Rheumatoid Arthritis

Name: RABIOPRED - a Validation Study of Theranostic Test to PREDict Treatment Response of Anti-TNFα BIologicals in Rheumatoid Arthritis
Published: 2016
License: Public Domain

TcLand Expression S.A. · 2016

ClinicalTrials.gov · Datasets · License: Public Domain · 2016

Open Source ↗

rheumatoid-arthritis

rheumatoid arthritis, anti tnf, infliximab, adalimumab, etanercept, golimumab, certolizumab pegol, infliximab biosimilar, etanercept biosimilar, methotrexate, observational

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

RABIOPRED - a Validation Study of Theranostic Test to PREDict Treatment Response of Anti-TNFα BIologicals in Rheumatoid Arthritis

Related documents